Cargando…
Genetic Study of Hepatocyte Nuclear Factor 1 Alpha Variants in Development of Early-Onset Diabetes Type 2 and Maturity-Onset Diabetes of the Young 3 in Iran
BACKGROUND: Maturity-onset diabetes of the young (MODY) is a clinically and genetically heterogeneous group of diabetes characterized by noninsulin-dependent, autosomal-dominant disorder with strong familial history, early age of onset, and pancreatic beta-cell dysfunction. Mutations in at least 14...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777141/ https://www.ncbi.nlm.nih.gov/pubmed/31673528 http://dx.doi.org/10.4103/abr.abr_54_19 |
_version_ | 1783456570057687040 |
---|---|
author | Mohammadi, Aliasgar Eskandari, Ameneh Sarmadi, Akram Rahimi, Mehrali Iraj, Bijan Hashemipour, Mahin Chaleshtori, Morteza Hashmezadeh Tabatabaiefar, Mohammad Amin |
author_facet | Mohammadi, Aliasgar Eskandari, Ameneh Sarmadi, Akram Rahimi, Mehrali Iraj, Bijan Hashemipour, Mahin Chaleshtori, Morteza Hashmezadeh Tabatabaiefar, Mohammad Amin |
author_sort | Mohammadi, Aliasgar |
collection | PubMed |
description | BACKGROUND: Maturity-onset diabetes of the young (MODY) is a clinically and genetically heterogeneous group of diabetes characterized by noninsulin-dependent, autosomal-dominant disorder with strong familial history, early age of onset, and pancreatic beta-cell dysfunction. Mutations in at least 14 different genes are responsible for various MODY subtypes. Heterozygous mutations in the hepatocyte nuclear factor 1 alpha (HNF1A) gene are responsible for the MODY3 subtype, which is a common subtype of MODY in different studied populations. To date, more than 450 different variants of this gene have been reported as disease causing for MODY3. This study was carried out to evaluate HNF1A mutations in Iranian diabetic families fulfilling MODY criteria. MATERIALS AND METHODS: Polymerase chain reaction and Sanger sequencing were performed. All the ten exons of the HNF1A gene were sequenced in ten families, followed by cosegregation analysis and in silico evaluation. Computational protein modeling was accomplished for the identified mutation. RESULTS: MODY3 was confirmed in two large families by detecting a mutation (p.G253E) in coding regions of HNF1A. Compound heterozygous state for two common variants in HNF1A (p.I27 L and p.S487N) was detected in affected members of 5 families, and in one family, a rare benign variant in the coding sequence for Kozak sequence was detected. Two new nonpathogenic variants were found in noncoding regions of HNF1A. CONCLUSION: It seems that HNF1A mutations are a common cause of MODY in Iranian diabetic patients. Identified common variants in heterozygous state can cause diabetes Type II in earlier ages. The role of rare variant rs3455720 is unknown, and more investigation is needed to uncover the function of this variant. |
format | Online Article Text |
id | pubmed-6777141 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-67771412019-10-31 Genetic Study of Hepatocyte Nuclear Factor 1 Alpha Variants in Development of Early-Onset Diabetes Type 2 and Maturity-Onset Diabetes of the Young 3 in Iran Mohammadi, Aliasgar Eskandari, Ameneh Sarmadi, Akram Rahimi, Mehrali Iraj, Bijan Hashemipour, Mahin Chaleshtori, Morteza Hashmezadeh Tabatabaiefar, Mohammad Amin Adv Biomed Res Original Article BACKGROUND: Maturity-onset diabetes of the young (MODY) is a clinically and genetically heterogeneous group of diabetes characterized by noninsulin-dependent, autosomal-dominant disorder with strong familial history, early age of onset, and pancreatic beta-cell dysfunction. Mutations in at least 14 different genes are responsible for various MODY subtypes. Heterozygous mutations in the hepatocyte nuclear factor 1 alpha (HNF1A) gene are responsible for the MODY3 subtype, which is a common subtype of MODY in different studied populations. To date, more than 450 different variants of this gene have been reported as disease causing for MODY3. This study was carried out to evaluate HNF1A mutations in Iranian diabetic families fulfilling MODY criteria. MATERIALS AND METHODS: Polymerase chain reaction and Sanger sequencing were performed. All the ten exons of the HNF1A gene were sequenced in ten families, followed by cosegregation analysis and in silico evaluation. Computational protein modeling was accomplished for the identified mutation. RESULTS: MODY3 was confirmed in two large families by detecting a mutation (p.G253E) in coding regions of HNF1A. Compound heterozygous state for two common variants in HNF1A (p.I27 L and p.S487N) was detected in affected members of 5 families, and in one family, a rare benign variant in the coding sequence for Kozak sequence was detected. Two new nonpathogenic variants were found in noncoding regions of HNF1A. CONCLUSION: It seems that HNF1A mutations are a common cause of MODY in Iranian diabetic patients. Identified common variants in heterozygous state can cause diabetes Type II in earlier ages. The role of rare variant rs3455720 is unknown, and more investigation is needed to uncover the function of this variant. Wolters Kluwer - Medknow 2019-09-23 /pmc/articles/PMC6777141/ /pubmed/31673528 http://dx.doi.org/10.4103/abr.abr_54_19 Text en Copyright: © 2019 Advanced Biomedical Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Mohammadi, Aliasgar Eskandari, Ameneh Sarmadi, Akram Rahimi, Mehrali Iraj, Bijan Hashemipour, Mahin Chaleshtori, Morteza Hashmezadeh Tabatabaiefar, Mohammad Amin Genetic Study of Hepatocyte Nuclear Factor 1 Alpha Variants in Development of Early-Onset Diabetes Type 2 and Maturity-Onset Diabetes of the Young 3 in Iran |
title | Genetic Study of Hepatocyte Nuclear Factor 1 Alpha Variants in Development of Early-Onset Diabetes Type 2 and Maturity-Onset Diabetes of the Young 3 in Iran |
title_full | Genetic Study of Hepatocyte Nuclear Factor 1 Alpha Variants in Development of Early-Onset Diabetes Type 2 and Maturity-Onset Diabetes of the Young 3 in Iran |
title_fullStr | Genetic Study of Hepatocyte Nuclear Factor 1 Alpha Variants in Development of Early-Onset Diabetes Type 2 and Maturity-Onset Diabetes of the Young 3 in Iran |
title_full_unstemmed | Genetic Study of Hepatocyte Nuclear Factor 1 Alpha Variants in Development of Early-Onset Diabetes Type 2 and Maturity-Onset Diabetes of the Young 3 in Iran |
title_short | Genetic Study of Hepatocyte Nuclear Factor 1 Alpha Variants in Development of Early-Onset Diabetes Type 2 and Maturity-Onset Diabetes of the Young 3 in Iran |
title_sort | genetic study of hepatocyte nuclear factor 1 alpha variants in development of early-onset diabetes type 2 and maturity-onset diabetes of the young 3 in iran |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777141/ https://www.ncbi.nlm.nih.gov/pubmed/31673528 http://dx.doi.org/10.4103/abr.abr_54_19 |
work_keys_str_mv | AT mohammadialiasgar geneticstudyofhepatocytenuclearfactor1alphavariantsindevelopmentofearlyonsetdiabetestype2andmaturityonsetdiabetesoftheyoung3iniran AT eskandariameneh geneticstudyofhepatocytenuclearfactor1alphavariantsindevelopmentofearlyonsetdiabetestype2andmaturityonsetdiabetesoftheyoung3iniran AT sarmadiakram geneticstudyofhepatocytenuclearfactor1alphavariantsindevelopmentofearlyonsetdiabetestype2andmaturityonsetdiabetesoftheyoung3iniran AT rahimimehrali geneticstudyofhepatocytenuclearfactor1alphavariantsindevelopmentofearlyonsetdiabetestype2andmaturityonsetdiabetesoftheyoung3iniran AT irajbijan geneticstudyofhepatocytenuclearfactor1alphavariantsindevelopmentofearlyonsetdiabetestype2andmaturityonsetdiabetesoftheyoung3iniran AT hashemipourmahin geneticstudyofhepatocytenuclearfactor1alphavariantsindevelopmentofearlyonsetdiabetestype2andmaturityonsetdiabetesoftheyoung3iniran AT chaleshtorimortezahashmezadeh geneticstudyofhepatocytenuclearfactor1alphavariantsindevelopmentofearlyonsetdiabetestype2andmaturityonsetdiabetesoftheyoung3iniran AT tabatabaiefarmohammadamin geneticstudyofhepatocytenuclearfactor1alphavariantsindevelopmentofearlyonsetdiabetestype2andmaturityonsetdiabetesoftheyoung3iniran |